International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Global Scenario of Antiviral Drugs for Japanese Encephalitis

Author Affiliations

  • 1Department of Botany, D.D.U. Gorakhpur University, Gorakhpur, U.P., India

Res. J. Recent Sci., Volume 5, Issue (10), Pages 48-52, October,2 (2016)


Japanese encephalitis a mosquito transmitted viral disease is a global confront for public health. The disease is a pediatric problem, the seriousness of the disease can be predicted as it mostly affects the children and the survivor are left with serious long term neuropsychiatric problems. Hence the disease is affecting our future generation. The only available option to control JE is vaccination but being a disease of low socioeconomic strata, affordable vaccines are still a demand. Therefore to overcome the present situation there is an imperative need for development of safe and affordable antiviral drugs for Japanese encephalitis. There are many promising antiviral agents against JE which need further evaluation. This review highlights the potential antiviral drugs which can be utilized for Japanese encephalitis.


  1. Srivastava D. and Shukla K. (2015)., Japanese encephalitis in Gorakhpur: A Review., Eup. J. Biomed. Pharma.Sci., 2(7), 118-124.
  2. Srivastava D., Pratap B. and Shukla K. (2016)., Impact of weather variables on mosquitoes infected with Japanese encephalitis virus in Gorakhpur district, Uttar-Pradesh., Proceedings from National conference on science for rural India, Deoria, U.P., India, 30-31st Jan., 178-181, ISBN: 978-81-929510-5-8.
  3. Saxena S.K., Agrawal P.T. and Nair M.P.N. (2014)., Current Scerario of Antiviral Drugs for Japanese encephalitis., J. Med. Microb. Diagn., 3(1), 1-3.
  4. Zhang Y., Wang Z., Chen H. and Chen Z. (2014)., Antioxidants: potential antiviral agents for Japanese encephalitis virus infection., Int. J. Infect. Dis., 24, 30-36.
  5. Lin C.W., Wu C.F., Hsiao N.W., Chang C.Y. and Li S.W. (2008)., Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71., Int. J. Antimicrob. Agents., 32(4), 355-359.
  6. Kajimura K., Takagi Y., Ueba N., Yamasaki K. and Sakagami Y. (1996)., Protective effect of Astragali Radix by intraperitonial injection against Japanese encephalitis virus infection in mice., Biol. Pharm. Bull., 19(6), 855-859.
  7. Swarup V., Ghosh J., Mishra M.K. and Basu A. (2008)., Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan., J. Antimicrob Chemother., 61(3), 679-688.
  8. Tomassoli I. and Gundisch D. (2016)., Bispidine as a privileged Scaffold., Curr. Topics in med. Chem., 16(11), 1314-1342.
  9. Dutta K., Ghosh D. and Basu A. (2009)., Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin–proteasome system., J. Neuroimmune Pharmacol., 4(3), 328-337.
  10. Chang C.C., Ou Y.C., Raung S.L. and Chen C.J. (2005)., Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection., J. Gen. Virol., 86(9), 2513-2523.
  11. Saxena S.K., Mathur A. and Srivastava R.C. (2003)., Inhibition of Japanese encephalitis virus infection by diethyldithiocarbamate is independent of its antioxidant potential., Antivir. Chem. Chemother., 14(2), 91-98.
  12. Sehgal N., Kumawat K.L., Basu A. and Ravindranath V. (2012)., Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection., PLoS One., (2012), 7, e35427, http://dx.doi.10.1371/ journal.pone.0035427.
  13. Johari J., Kianmehr A., Mustafa M.R., Abubakar S. and Zandi K. (2012)., Antiviral activity of Baicalein and Quercetin against the Japanese Encephalitis virus., Int. J. Mol. Sci., 2012(13), 16785-16795.
  14. Takegami T., Simamura E., Hiraik I. and Koyama J. (1998)., Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus., Antivir. Res., 37(1), 37-45.
  15. Ishag H.Z.A., Li C., Wang F. and Mao X. (2016)., GRFT binds to glycosylated proteins (E and prM) of Japanese encephalitis virus and inhibits its infection., Vir. Res., 215(2016), 50-54.
  16. Chang S.J., Chang Y.C., Lu K.Z., Tsou Y.Y. and Lin C.W. (2012)., Antiviral Activity of Isatis indigotica Extract and Its Derived Indirubin against Japanese Encephalitis Virus Evidence., Evid. Based complement. Alternat. Med., 2012(925830), 1-7, http://dx.doi: 10.1155/2012/925830.
  17. Zhang T., Wu Z., Du J., Hu Y., Liu L., Yang F. and Jin Q. (2012)., Anti- Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding Characteristics., Plos.One.,7(1), 30259. http://dx.doi:10. 1371/2012/0030259.
  18. Chien Y.J., Chen W.J., Hsu W.L. and Chiou S.S. (2008)., Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparin sulfate and receptor for low density lipoprotein., Virol., 379(1), 13-51.
  19. Singh A., Mehta A., Kushwah K.P., Pandey A.K., Mittal M., Sharma B. and Pandey J. (2016)., Minocycline trial in Japanese encephalitis: a double blind, randomized placebo study., Int. J. of Pediatr. Res., 3(5), 371-377.
  20. Saxena S.K., Singh A. and Mathur A. (2000)., Antiviral effect of nitric oxide during Japanese encephalitis virus infection., Int.J.Exp.Pathol., 81(2), 165-172.
  21. Sebastian L., Madhusudana S.N., Ravi V. and Desai A. (2011)., Mycophenolic acid inhibits replication of Japanese encephalitis virus., Chemother., 57(1), 56-61.
  22. Shi Z., Wei J., Deng X., Li S., Qui Y., Shao D., Li B., Zhang K., Xue F., Wang X. and Ma Z. (2014)., Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model., Vir. J., 11(10), 10. 1186/1743-422X-11-10.
  23. Sebastina L., Desai A., Madhusudana Narayan S. and Vasantapuram R. (2009)., Pentaxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin., Int. J. Antimicro. Agen., 33(2), 168-173.
  24. Ishag H.Z., Li. C., Huang L., Sun M.X., Ni B., Guo C.X. and Mao X. (2013)., Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antivial protein., Virus Res., 171(1), 89-96.
  25. Chang S.J., Huang S.H., Lin Y.J., Tsou Y.Y. and Lin C.W. (2014)., Antiviral activity of Rheum palmatum methanol extract and chrysophanol against Japanese encephalitis virus., Arch. Pharm. Res., 37(9), 1117-23.
  26. Swarup V., Ghosh J., Ghosh S., Saxena A. and Basu A. (2007)., Antiviral and anti-inflammatory effects of rosamic acid in an experimental murine model of Japanese encephalitis., Antimicrob. Agents Chemother., 51(9), 3367-3370.
  27. Shen T., Liu K., Miao D., Cao R. and Chen P. (2014)., Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo., Virol., 454, 48-49.
  28. Huang H.N., Rajanbabu V., Pan C.Y., Chan Y.L. and Hui C.F. (2011)., Modulation of the immune related gene responses to protect mice against Japanese encephalitis using antimicrobial peptide, tilapia hepcidin 1-5., Biomat., 32, 6804-6814.
  29. Roy S., Chaurvedi P. and Chowdhary A. (2015)., Evaluation of antiviral activity of essential oil of Trachyspermum Ammi against Japanese encephalitis virus., Phcog. Res., 7(3), 263-267.
  30. Liang J.L., Wei J.C., Lee Y.L., Hsu S.H., Lin J.J. and Lin Y.L. (2014)., Surfactant-modified Nanoclay exhibits an antiviral activity with high potency and broad spectrum., J.Virol., 88(8), 4218-4228